OrganOx Limited

Japanese medical device maker Terumo has agreed to acquire U.K.-based OrganOx, a commercial-stage organ technology company, for approximately $1.5 billion. The acquisition marks Terumo's entry into the organ transplant market.

Terumo Corporation has entered into a definitive agreement to acquire all outstanding shares of OrganOx Limited, a medical technology company specializing in organ preservation devices, for approximately $1.5 billion.